3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
HIV Infections
1
Brain Neoplasms
1
Interventions
Whole-Body Irradiation
4
Cyclophosphamide
4
fludarabine phosphate
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
fludarabine
2
Tacrolimus
2
Sirolimus
2
Melphalan
2
Busulfan
2
Transplantation
1
Radiotherapy
1
Methotrexate
1
Health Promotion
1
Etoposide
1
Educational Status
1
Cyclosporine
1
Antilymphocyte Serum
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Aplastic
×
Valganciclovir
×
90 days
×
Clear all
No trials found.